Eif4ebp2, encoding the suppressor of mRNA translation initiation 4E-BP2, is a key component in the regulation of mRNA translation. It binds to eukaryotic initiation factor 4E (eIF4E), sequestering it and blocking cap-dependent translation, thus regulating cell growth and proliferation. It is involved in the mTORC1 signaling pathway, which is crucial for coordinating cell metabolism, growth, and survival in response to various stimuli [1,2,3].

In Eif4ebp2(-/-) mice, there is an imbalance in excitatory-to-inhibitory neurotransmission and ASD-like behaviors. These phenotypes can be reversed by antagonists of group I metabotropic glutamate receptors (mGluRs), suggesting that Eif4ebp2 plays a role in regulating synaptic physiology and behaviors relevant to autism spectrum disorders (ASDs) [4]. Also, in a study on cervical cancer, down-regulated circ_0000190 promotes cancer progression by weakening the binding ability of EIF4EBP2 to eIF4E, indicating its potential tumor-suppressive role [2].

In conclusion, Eif4ebp2 is essential for regulating mRNA translation, with implications in multiple biological processes. Gene-knockout mouse models, like Eif4ebp2(-/-) mice, have revealed its role in diseases such as ASDs and cervical cancer. These findings enhance our understanding of the molecular mechanisms underlying these diseases and may provide new therapeutic targets.